Amlodipine + Hydrochlorothiazide, a combination of calcium-channel blocker and potassium-losing diuretic, is indicated for the treatment and management of hypertension. The drugs improve blood flow by dilatation of blood vessels.

Feeling short of breath, even with mild exertion; swelling of your ankles or feet; slow or uneven heartbeats; or numbness or cold feeling in your hands and feet.

Amlodipine + Hydrochlorothiazide may interact with NSAIDs, cholestipol, sedating anti-histaminic drugs, Cholestyramine, lithium, cisaperide, dofetilide and certain cough drugs.

Amlodipine: USFDA pregnancy category C. May be or may not be harmful to an unborn baby. Consult your doctor if you are in gestation or planning to have a baby during Amlodipine treatment. Hydrochlorothiazide: USFDA pregnancy category B. Hydrochlorothiazide may not cause harm to an unborn foetus. Before Hydrochlorothiazide treatment, the patient should discuss with the physician, if they are planning for a pregnancy.

Amlodipine + Hydrochlorothiazide, a combination of calcium-channel blocker and potassium-losing diuretic.The drugs improve blood flow by dilatation of blood vessels and by increasing urinary output.

sastimedic.com is not intended to provide diagnosis, treatment or medical advice. Products, Services, Information and other content provided on this site are for informational purposes only. sastimedic does not recommend self management of health issues, information on this is site is not comprehensive and does not cover all diseases, ailments, physical conditions or their treatment. Contact your healthcare professional for any diagnosis or treatment options.

Editorial Policy: Written/Reviewed by Content Management Team Under Chief editor: Surjeet Singh